Skip to content

PlaCEUS

Feasibility study of contrast-enhanced ultrasound to visualize maternal uterine spiral arteries postpartum. - PlaCEUS

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON58107
Enrollment
5
Registered
2025-09-09
Start date
2026-02-11
Completion date
Unknown
Last updated
2026-07-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Spiral arteries remodelling and uterine artery hemodynamics changes peripartum Adaption of spiral arteries based on the needs of the baby and quality assessment of the uterine artery before, during and after delivery.

Interventions

Uterine artery Doppler measurements (resistance index, pulsatility index, systolic/diastolic ratio)&nbsp
before delivery, during delivery and postpartum, which will take approximately 3-5 minutes. Before and during delivery, the transition of spiral arteries into the intervillous space&nbsp
will be identified using colour Doppler.&nbsp
Postpartum CEUS, using SonoVue™, administered via the already in place intravenous infusion system. A bolus of 2,4 mL is given followed by a 10mL&nbsp
sodium chloride (0.9%) flush, after which potential persisting spiral arteries will be examined using GE Healthcare Voluson E8 ultrasound. This measurement takes several minutes, based on the average

Sponsors

Máxima MC
Lead Sponsor

Eligibility

Age
18 Years to 64 Years

Inclusion criteria

Inclusion criteria: Pregnant patient at a minimum age of 18 yearsSingleton pregnancy at term (=37 weeks gestation)Planning to deliver at the Máxima Medical Centre Able to provide informed consentIntravenous access present at the time of delivery 

Exclusion criteria

Exclusion criteria: Multiple gestation pregnancyContra-indications to CEUS, e.g. known allergy for constituents of SonoVue™ Planning on breastfeedingMedical emergency during or after delivery, which makes CEUS impossible or undesirable No intravenous access present at the time of deliveryBody Mass Index >40 kg/m2. Pre-eclampsia requiring medicationFetal growth restriction < p3

Design outcomes

Primary

MeasureTime frame
The main study parameters is are to assess the visibility of spiral arteries and the feasibility of CEUS to visualizing and characterizing the persistence of maternal uterine spiral arteries. 

Secondary

MeasureTime frame
Secondary objectives are to evaluate uterine artery Doppler parameters before delivery, during delivery and within 4 hours postpartum to be able to describe peripartum changes in uterine artery hemodynamics, to subsequently correlate CEUS findings at 4 hours postpartum with uterine artery Doppler parameters. Before and during delivery, the transition of spiral arteries into the intervillous space will be identified using colour Doppler. 

Countries

Netherlands

Contacts

Public ContactE.M.L. Dekker

Máxima MC

PlaCEUS@mmc.nl-

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP) · Data processed: Jul 23, 2026